Financhill
Back

Novavax Stock Predictions

Novavax Stock Forecast

  • Over the next 52 weeks, Novavax has on average historically risen by 117.2% based on the past 28 years of stock performance.
  • Novavax has risen higher in 16 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is Novavax Stock Undervalued?
    The current Novavax [NVAX] share price is $8.72. The Score for NVAX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NVAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Novavax Stock Go Up Next Year?

  • Over the next 52 weeks, Novavax has on average historically risen by 117.2% based on the past 28 years of stock performance.

Novavax Stock Rating

Sell
25
Novavax (NVAX) is a Sell

Is Novavax overpriced?

  • Novavax has risen higher in 16 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Novavax Stock Price History

Is NVAX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVAX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
novavax.com

52-Week Data

52-Week High:
23.86
52-Week Low:
3.53

Prediction Charts

Market Cap:
1.4B
Price in USD:
8.72
Volume:
6.1M
Beta:
1.65

Technical Analysis

SMA50:
9.26
SMA100:
10.86
SMA200:
10.49
52-Wk Change:
77.49%

Stock Predictions

  • Is Novavax stock public?
    Yes, Novavax is a publicly traded company.
  • What is the Novavax stock quote today?
    The Novavax stock price is 8.72 USD today.
  • How to buy Novavax stock online?
    You can buy Novavax shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 8.77 8.41 8.80 8.35
Dec-4 8.53 8.30 8.55 8.15
Dec-5 8.30 8.30 8.45 8.13
Dec-6 8.40 8.94 9.55 8.40
Dec-9 9.01 9.07 9.23 8.92
Dec-10 9.10 8.77 9.16 8.71
Dec-11 8.83 8.82 8.89 8.66
Dec-12 8.77 9.02 9.29 8.66
Dec-13 9.00 9.11 9.29 8.88
Dec-16 9.17 9.23 9.75 9.08
Dec-17 9.16 9.00 9.26 8.91
Dec-18 9.00 8.63 9.19 8.50
Dec-19 8.75 8.68 8.92 8.51
Dec-20 8.59 8.72 8.89 8.37

Novavax Earnings

Novavax Earnings Report: Per Share Novavax Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novavax Forecast Revenue Growth

Novavax Stock Analysis: Historical quarterly revenues per share for Novavax and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.39 per share, and an increase next year of $1.83 per share.

* Novavax stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.